Conventional heart drug stops the progression of cancer

(Texas Tech University Health Sciences Center El Paso) A common heart drug may stop the progression of angiosarcoma, a cancer of the inner lining of blood vessels, according to a study by researchers at Texas Tech University Health Sciences Center El Paso.